SecBot SecBot
SECBOTREPLAY Home › Report › NRIX

NRIX · Christine Ring, an officer of Nurix Therapeutics, filed a Form 144…

Nurix Therapeutics, Inc. · 144 filed Nov 3, 2026 at 16:26 ET

At the news

NEUTRALIMPACT 2/10

144 filed Nov 3, 2026 at 16:26 ET

Christine Ring, an officer of Nurix Therapeutics, filed a Form 144 notice of intent to sell 6,113 shares of common stock, with an estimated aggregate market value of approximately $157,104. The filing also discloses four prior 10b5-1 plan sales executed between September and November 2026, totaling 22,175 shares. This is a routine insider sale under a pre-arranged trading plan, representing a small fraction of the company's $3.0B market cap.

  • Christine Ring, an officer, filed Form 144 to sell 6,113 shares of common stock.
  • Estimated aggregate market value of the proposed sale is $157,104.10.
  • The filing also reports four prior 10b5-1 plan sales from September to November 2026 totaling 22,175 shares.
  • The proposed sale represents about 0.005% of the company's $3.0B market cap.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access